StockData

Neuraxis vs Vivani Medical

NRXS and VANI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How NRXS and VANI compare

Vivani Medical is the larger company, worth 1.5 times as much as Neuraxis ($92.0M against $60.3M).

Vivani Medical scores higher on the StockData Score (5 against 0 for Neuraxis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricNRXSVANI
Size and price
Market cap$60.3M$92.0M
Share price$4.80$1.02
Change, 1 year104%−24.7%
Change, 5 years–−83.7%
Beta (5Y)0.622.03
Employees2436
StockData Score
Total score05 (better)
Valuation score00
Growth score00
Performance score00
Health score05 (better)
Dividend score00
Valuation
P/B–4.9×
FCF yield–−28.8%
Profitability
Return on equity–−220%
Financial health
Debt / equity–0.00
Current ratio–3.25
Altman Z-score–−4.73
Piotroski F-score–2
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions21.7%5.8%
Held by insiders39.9%53.5%
Insider net buying, 12 months$1.4M$16.7M (better)
Short interest, % of float6.0%0.88%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.